Evidence map›Paper›PMID 33064342›Full record

SynthesisHuman brain mapping2022

Predicting alcohol dependence from multi-site brain structural measures.

Sage Hahn, Scott Mackey, Janna Cousijn, John J Foxe, Andreas Heinz, Robert Hester, Kent Hutchinson, Falk Kiefer, Ozlem Korucuoglu, Tristram Lett and 21 more

Open access · goldAbstract readMeta-AnalysisMulticenter Study
In one paragraph

Synthesis in Human brain mapping, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. ENIGMA-Meditation: Worldwide Consortium for Neuroscientific Investigations of Meditation Practices.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2025
    Review
  8. Article
  9. Article
  10. Neuroimaging Biomarkers in Addiction.medRxiv : the preprint server for health sciences · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. RNA biomarkers for alcohol use disorder.Frontiers in molecular neuroscience · 2022
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 20 institutions in 7 countries.

Sage HahnDepartment of Psychiatry, University of Vermont College of Medicine, Burlington, Vermont, USA.ORCID 0000-0003-3560-2952
Scott MackeyDepartment of Psychiatry, University of Vermont College of Medicine, Burlington, Vermont, USA.
Janna CousijnDepartment of Psychology, University of Amsterdam, Amsterdam, the Netherlands.
John J FoxeDepartment of Neuroscience & The Ernest J. Del Monte Institute for Neuroscience, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Andreas HeinzDepartment of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Robert HesterMelbourne School of Psychological Sciences, University of Melbourne, Melbourne, Australia.
Kent HutchinsonDepartment of Psychology and Neuroscience, University of Colorado, Boulder, Colorado, USA.
Falk KieferDepartment of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany.
Ozlem KorucuogluDepartment of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
Tristram LettDepartment of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Chiang-Shan R LiDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-9393-1212
Edythe LondonDavid Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
Valentina LorenzettiMonash Institute of Cognitive and Clinical Neurosciences & School of Psychological Sciences, Monash University, Melbourne, Australia.
Luijten MaartjeBehavioural Science Institute, Radboud University, Nijmegen, the Netherlands.
Reza MomenanClinical NeuroImaging Research Core, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.
Catherine OrrDepartment of Psychiatry, University of Vermont College of Medicine, Burlington, Vermont, USA.
Martin PaulusVA San Diego Healthcare System and Department of Psychiatry, University of California San Diego, La Jolla, California, USA.
Lianne SchmaalOrygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
Rajita SinhaDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Zsuzsika SjoerdsDepartment of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Dan J SteinSA MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry & Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Elliot SteinNeuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA.
Ruth J van HolstDepartment of Psychiatry, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, the Netherlands.
Dick VeltmanDepartment of Psychiatry, VU University Medical Center, Amsterdam, the Netherlands.
Henrik WalterDepartment of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Reinout W WiersDepartment of Psychology, University of Amsterdam, Amsterdam, the Netherlands.
Murat YucelDavid Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
Paul M ThompsonImaging Genetics Center, Stevens Institute for Neuroimaging & Informatics, Keck School of Medicine, University of Southern California, California, USA.
Patricia ConrodDepartment of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montreal, Quebec, Canada.
Nicholas AllgaierDepartment of Psychiatry, University of Vermont College of Medicine, Burlington, Vermont, USA.
Hugh GaravanDepartment of Psychiatry, University of Vermont College of Medicine, Burlington, Vermont, USA.
University of Vermont · USCharité - Universitätsmedizin Berlin · DEThe University of Melbourne · AUUniversity of Amsterdam · NLUniversity of California, Los Angeles · USYale University · USAmsterdam UMC Location Vrije Universiteit Amsterdam · NLAmsterdam University Medical Centers · NLHeidelberg University · DELeiden University · NLNational Institute on Alcohol Abuse and Alcoholism · USNational Institute on Drug Abuse · USRadboud University Nijmegen · NLUniversité de Montréal · CAUniversity of California San Diego · USUniversity of Cape Town · ZAUniversity of Colorado Boulder · USUniversity of Liverpool · GBUniversity of Rochester · USUniversity of Southern California · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Brain Imaging of Human Drug AbuseZIADA000470 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI STEIN, ELLIOT A · 2009 to 2021
$15.8M
Neuroimaging of Alcohol Use DisorderZIAAA000125 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI MOMENAN, REZA · 2016 to 2025
$12.4M
Chronic Alcohol and Brain Stress Circuit ResponseR01AA013892 · NIAAA · YALE UNIVERSITY · PI Rajita Sinha · 2003 to 2026
$10.1M
Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
ENIGMA- Addiction: Pooling of Existing Datasets to Identify Brain and Genetic Correlates of Addiction, Next StepsR01DA047119 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HUGH P. GARAVAN · 2018 to 2026
$5.4M
Protocols, Statistics, Collaborative Method Development and ToolsPL1DA024859 · NIDA · YALE UNIVERSITY · PI SINHA, RAJITA · 2007 to 2011
$3.6M
Neural Systems, Inhibitory Control, and Methamphetamine DependenceR01DA020726 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LONDON, EDYTHE DANICK · 2005 to 2008
$2.0M
The Role of Executive Functions in Cocaine AbuseR01DA014100 · NIDA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI GARAVAN, HUGH P. · 2001 to 2008
$1.9M
STIMULANT DEPENDENCE: NEURAL MECHANISMS OF RELAPSER01DA018307 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PAULUS, MARTIN P. · 2004 to 2008
$1.3M
Training in Complex Systems and Data Science Approaches Applied to the Neurobiology of Drug UseT32DA043593 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI DODDS, PETER S., GARAVAN, HUGH P. · 2018 to 2022
$1.2M
Interdisciplinary Research on Stress, Self-Control & AddictionUL1RR024925 · NCRR · YALE UNIVERSITY · PI SINHA, RAJITA · 2007 to 2007
$849k
Intramural NIH HHS ZIA AA000125NCATS NIH HHS UL1 TR001863NCRR NIH HHS UL1 RR024925NIAAA NIH HHS R01 AA013892NIAAA NIH HHS R01-AA013892NIAAA NIH HHS ZIA AA000125-04 DICBNIBIB NIH HHS U54 EB020403NIDA NIH HHS PL1 DA024859NIDA NIH HHS PL30-1DA024859-01NIDA NIH HHS R01 DA014100NIDA NIH HHS R01-DA014100NIDA NIH HHS R01 DA018307NIDA NIH HHS R01 DA020726NIDA NIH HHS R01-DA020726NIDA NIH HHS R01 DA047119NIDA NIH HHS R01DA047119NIDA NIH HHS T32 DA043593NIDA NIH HHS T32DA043593NIH HHS R01 DA018307NIH HHS U54 EB020403NIH HHS UL1-RR24925-01
6 · The paper itself

Abstract

To identify neuroimaging biomarkers of alcohol dependence (AD) from structural magnetic resonance imaging, it may be useful to develop classification models that are explicitly generalizable to unseen sites and populations. This problem was explored in a mega-analysis of previously published datasets from 2,034 AD and comparison participants spanning 27 sites curated by the ENIGMA Addiction Working Group. Data were grouped into a training set used for internal validation including 1,652 participants (692 AD, 24 sites), and a test set used for external validation with 382 participants (146 AD, 3 sites). An exploratory data analysis was first conducted, followed by an evolutionary search based feature selection to site generalizable and high performing subsets of brain measurements. Exploratory data analysis revealed that inclusion of case- and control-only sites led to the inadvertent learning of site-effects. Cross validation methods that do not properly account for site can drastically overestimate results. Evolutionary-based feature selection leveraging leave-one-site-out cross-validation, to combat unintentional learning, identified cortical thickness in the left superior frontal gyrus and right lateral orbitofrontal cortex, cortical surface area in the right transverse temporal gyrus, and left putamen volume as final features. Ridge regression restricted to these features yielded a test-set area under the receiver operating characteristic curve of 0.768. These findings evaluate strategies for handling multi-site data with varied underlying class distributions and identify potential biomarkers for individuals with current AD.

Indexed as

Machine LearningMagnetic Resonance ImagingMulticenter Studies as TopicNeuroimagingAlcoholismCerebral CortexHumansPutamenReproducibility of Resultsaddictionalcohol dependencegenetic algorithmmachine learningmulti-sitepredictionstructural MRI

Identifiers

PMID33064342
PMCPMC8675424
OpenAlexW3093398614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.